Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Aveeno Positively Radiant Eye CC Cream Broad Spectrum SPF 25 - fair to light
- Manufacturer
- Johnson & Johnson Consumer Inc.
- Effective date
- 2023-01-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:38:39
Label at a glance#
ProductAveeno Positively Radiant CC Eye Broad Spectrum SPF25 - Fair to Light
Active ingredientTITANIUM DIOXIDE
Label structure11 sections
Dosage and administration
For sunscreen use: apply generously and evenly 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: lim...
Storage and handling
protect this product from excessive heat and direct sun may stain some fabrics
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active Ingredient
Titanium Dioxide (1.88%)
Purpose
Sunscreen
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away
Directions
For sunscreen use:
- apply generously and evenly 15 minutes before sun exposure
- reapply at least every 2 hours
- use a water resistant sunscreen if swimming or sweating
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
- children under 6 months of age: Ask a doctor
Other Information
- protect this product from excessive heat and direct sun
- may stain some fabrics
Inactive Ingredients
Water, Cyclopentasiloxane, Talc, Butylene Glycol, Cyclohexasiloxane, Polyglyceryl-4 Diisostearate/Polyhydroxystearate/Sebacate, Ethylhexyl Palmitate, C12-15 Alkyl Benzoate, Tetrahydroxypropyl Ethylenediamine, Cetyl PEG/PPG-10/1 Dimethicone, Boron Nitride, Cetyl Dimethicone, Magnesium Sulfate, Ozokerite, Polybutene, Citric Acid, Polymethylsilsesquioxane, Myristyl Alcohol, 1,2-Hexanediol, Caprylyl Glycol, Cocoglycerides, Saccharomyces Lysate Extract, Aluminum Starch Octenylsuccinate, Propylparaben, DMDM Hydantoin, Silica Silylate, Alumina, Glyceryl Laurate, Polyhydroxystearic Acid, Silica, Stearyl Alcohol, Dimethicone, Triethoxycaprylylsilane, Glycine Soja (Soybean) Seed Extract, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Tocopherol, Hydrogenated Vegetable Glycerides, Chrysanthemum Parthenium (Feverfew) Flower/Leaf/Stem Juice, Distearyl Ether, Acrylates Copolymer, Magnesium Carbonate, Pentylene Glycol, Titanium Dioxide, Iron Oxides, Mica
Questions?
Call toll-free 866-428-3366 or 215-273-8755 (collect) or visit 
www.aveeno.com
SPL UNCLASSIFIED SECTION
Distributed by:
JOHNSON & JOHNSON
CONSUMER PRODUCTS
COMPANY
Division of Johnson & Johnson
Consumer Companies, Inc.
Skillman, NJ 08558-9418
PRINCIPAL DISPLAY PANEL - 15 mL Tube Carton
CC Eye
Cream
with
titanium
dioxide
sunscreen
BROAD
SPECTRUM
SPF 25
fair to
light
sheer tint
instantly
conceals,
brightens
and
protects
0.50 fl. Oz.
(15 mL)
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| 1,2-Hexanediol | INACTIVE INGREDIENT | TR046Y3K1G | 1 | |
| Alkyl (C12-15) Benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| Aluminum Oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| Aluminum Starch Octenylsuccinate | INACTIVE INGREDIENT | I9PJ0O6294 | 1 | |
| Boron Nitride | INACTIVE INGREDIENT | 2U4T60A6YD | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| Coco-Glycerides | INACTIVE INGREDIENT | ISE9I7DNUG | 1 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| Cyclomethicone 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Distearyl Ether | INACTIVE INGREDIENT | SC6T3MJF8Y | 1 | |
| DMDM Hydantoin | INACTIVE INGREDIENT | BYR0546TOW | 1 | |
| Edetol | INACTIVE INGREDIENT | Q4R969U9FR | 1 | |
| Ethylhexyl Palmitate | INACTIVE INGREDIENT | 2865993309 | 1 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| Glyceryl Laurate | INACTIVE INGREDIENT | Y98611C087 | 1 | |
| Magnesium Carbonate | INACTIVE INGREDIENT | 0E53J927NA | 1 | |
| Magnesium Sulfate | INACTIVE INGREDIENT | DE08037SAB | 1 | |
| Mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| Myristyl Alcohol | INACTIVE INGREDIENT | V42034O9PU | 1 | |
| Pentaerythritol Tetrakis(3-(3,5-Di-Tert-Butyl-4-Hydroxyphenyl)Propionate) | INACTIVE INGREDIENT | 255PIF62MS | 1 | |
| Pentylene Glycol | INACTIVE INGREDIENT | 50C1307PZG | 1 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| Saccharomyces Lysate | INACTIVE INGREDIENT | R85W246Z1C | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Soybean | INACTIVE INGREDIENT | L7HT8F1ZOD | 1 | |
| Stearyl Alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 1 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| Tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| Triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Aveeno Positively Radiant CC Eye Broad Spectrum SPF25 - Fair to Light
- Titanium Dioxide
- WATER
- CYCLOMETHICONE 5
- TALC
- BUTYLENE GLYCOL
- CYCLOMETHICONE 6
- ETHYLHEXYL PALMITATE
- ALKYL (C12-15) BENZOATE
- EDETOL
- BORON NITRIDE
- MAGNESIUM SULFATE, UNSPECIFIED FORM
- CITRIC ACID MONOHYDRATE
- MYRISTYL ALCOHOL
- 1,2-HEXANEDIOL
- CAPRYLYL GLYCOL
- COCO-GLYCERIDES
- SACCHAROMYCES LYSATE
- ALUMINUM STARCH OCTENYLSUCCINATE
- PROPYLPARABEN
- DMDM HYDANTOIN
- ALUMINUM OXIDE
- GLYCERYL LAURATE
- SILICON DIOXIDE
- STEARYL ALCOHOL
- DIMETHICONE
- TRIETHOXYCAPRYLYLSILANE
- SOYBEAN
- PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE)
- TOCOPHEROL
- DISTEARYL ETHER
- MAGNESIUM CARBONATE
- PENTYLENE GLYCOL
- FERRIC OXIDE RED
- MICA
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 58232-0010 | 58232-0010-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| Magnesium Sulfate | MAGNESIUM SULFATE | DE08037SAB | CAPSULE / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| Myristyl Alcohol | MYRISTYL ALCOHOL | V42034O9PU | SUSPENSION / TOPICAL | 1.05 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | ENEMA / RECTAL | 0.02 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| Tocopherol | TOCOPHEROL | R0ZB2556P8 | CAPSULE, COATED / ORAL | 0.25 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| Magnesium Carbonate | MAGNESIUM CARBONATE | 0E53J927NA | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 84 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| Glyceryl Laurate | GLYCERYL LAURATE | Y98611C087 | FILM, EXTENDED RELEASE / TRANSDERMAL | 2.48 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| Magnesium Carbonate | MAGNESIUM CARBONATE | 0E53J927NA | CAPSULE, DELAYED RELEASE / ORAL | 180 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| Aluminum Oxide | ALUMINUM OXIDE | LMI26O6933 | SPONGE / TOPICAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION, EXTENDED RELEASE / ORAL | 4 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | GEL / TOPICAL | 4 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| Talc | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| Aluminum Starch Octenylsuccinate | ALUMINUM STARCH OCTENYLSUCCINATE | I9PJ0O6294 | CREAM / TOPICAL | 321 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET / ORAL | 20 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| Talc | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| Magnesium Sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CREAM / TOPICAL | 6 mg | ||
| Talc | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| Myristyl Alcohol | MYRISTYL ALCOHOL | V42034O9PU | TABLET, EXTENDED RELEASE / ORAL | 2 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f37d7032-6725-105b-e053-2995a90a3169 | 0fe4a571-4610-488e-a108-5b5b964a4f47 | 2023-01-30 | Warnings | f37d7032-6725-105b-e053-2995a90a3169 0fe4a571-4610-488e-a108-5b5b964a4f47 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.